Archive for the "Mesothelioma Lawyers Web" Category

No articles in this category.

Sort by:

Multaq Warnings Information

Multaq Warnings : Insulin, the substance that keeps our glucose (blood sugar) levels from becoming too elevated, guides glucose from our bloodstream into the body’s muscle, fat, and liver cells. The cells convert the glucose into energy, but if the glucose isn’t metabolized correctly (i.e., if the cells resist the insulin and won’t allow it to do its job), then we produce less energy and feel fatigued.

People who are insulin-resistant can’t use insulin efficiently, and glucose builds in the blood, prompting the pancreas to produce even more insulin in an attempt to rid the body of the excess glucose. The result is an abundance of fatty acids that are converted to fat, which is stored in the liver, creating nonalcoholic fatty liver disease. Almost all people with NAFLD are insulin-resistant. Although overweight people are more likely to exhibit insulin resistance than people of normal weight, a sedentary lifestyle and a high-fat, high-sugar diet triggers insulin resistance regardless of body weight or body mass index.

The combination of factors and related disorders of metabolism (obesity, insulin resistance, diabetes, hypertriglyceridemia, and hypertension) comprises the group of findings known as the metabolic syndrome. People with the metabolic syndrome generally also have NAFLD, which in some cases will have progressed to NASH.

An easy way to distinguish between nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is to put them into alphabetical order: NAFLD, or fatty liver disease, comes before NASH, or nonalcoholic steatohepatitis. This mnemonic is helpful because it reflects the order in which the two diseases occur: fatty liver disease arises first and can progress to nonalcoholic steatohepatitis.

Here are some facts at a glance:

•       Simple fatty liver (which is, just as its name describes, an accumulation of fat in the liver) is the beginning stage of nonalcoholic fatty liver disease. It is caused by insulin resistance, meaning that the insulin produced in the body is less effective than it should be. The primary factor in the development of insulin resistance is obesity, especially central obesity, or the accumulation of a disproportionate amount of weight in the abdomen. Simple fatty liver is relatively harmless and often disappears with weight loss.

•       The next stage of nonalcoholic fatty liver disease is nonalcoholic steatohepatitis. When NASH occurs, the liver is still fatty, but it also becomes inflamed (hepatitis) and liver cells can be destroyed. It can progress to scarring of the liver (fibrosis) and development of severe liver diseases, including cirrhosis, which is the last stage of NAFLD.

The Centers for Disease Control estimates that an astonishing 90 percent of people who are obese or have been diagnosed with type 2 diabetes also have simple fatty liver. About 20 percent of them have NASH, and 10 percent have cirrhosis.

More information on Multaq Warnings

A high-fat diet, obesity, and insulin resistance are the most common causes of nonalcoholic fatty liver disease, but there are other, less common causes. One is drug-induced steatohepatitis, or more precisely drug-induced fatty liver, which is caused by medications such as prednisone (a steroid), tamoxifen (used in treating breast cancer), estrogen (a female hormone), methotrexate (used to treat

cancer and autoimmune conditions), amiodarone (used to treat heart conditions), or Arimidex (used to treat breast cancer).

Early symptoms of fatty liver disease are vague and nonspecific and include fatigue, malaise, and/or an ache in the upper right abdomen (where the liver is located).

Symptoms that appear in the advanced stages of nonalcoholic steatohepatitis mimic those of cirrhosis and include fluid in the abdominal cavity (ascites), severe itching, swelling (edema) of the legs and feet, weakness, nausea, easy bruising, yellowing of the skin and eyes (jaundice), dark (cola-colored) urine, and mental confusion.

To diagnose the problem, a physician may prescribe blood tests to rule out other liver-damaging conditions, including hepatitis B and C. Because excessive alcohol consumption can can cause fatty liver and alcoholic steatohepatitis (ASH), you may be asked about how much alcohol you consume. Excessive quantities are defined as three or more drinks a day for men and two or more drinks for women.

If fatty liver is suspected, the doctor will probably order further tests, including a liver-function blood test to measure whether enzymes are elevated (signaling possible liver damage), an ultrasound or a CT scan, and possibly a liver biopsy.

Information from other sources on Multaq Warnings

One of the great health-care myths in our society is that iron supplements will pep you up and harmlessly make you a more energetic person. Most adults remember television commercials for breakfast cereals, tonics, and pills packed with iron that promised to cure our iron-poor blood. But few people realize that for anyone whose blood is already rich in iron, the addition of ferrous sulfate or iron supplements can do severe, irreparable damage to the liver and heart.

It is true that iron is essential to good health. Iron helps to form oxygen-carrying hemoglobin in our red blood cells, boosting brain function, producing energy, and giving us strong muscles and immune systems. For people who suffer from iron deficiency, anemia, or whose iron stores become diminished during pregnancy, iron supplementation is essential.

Normally, our bodies absorb only about 10 percent of the iron that we consume in food. Most iron circulates in the body in the form of hemoglobin, but some is also stored in the liver, bone marrow, and spleen. People with hemochromatosis, though, can absorb up to 20 percent or more of the iron they take in—twice as much as they need to replace iron lost from the body.

Our use of the term or terms Multaq Warnings is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Warnings visit our site often.

http://www.seedol.com

Multaq Lawsuit

Multaq Lawsuit :

Diagnosis

Diagnosis of hepatitis D virus infection is determined by blood testing. In acute co-infection, IgM and IgG antibodies to hepatitis D virus are detectable during the course of infection. IgM antibodies will be detected earlier after acute infection and IgG later or while the patient is recovering. IgG antibody concentrations in blood generally fall to levels that cannot be detected after the acute infection resolves. There is no reliable marker that persists to indicate past infection with hepatitis D virus. In hepatitis D virus superinfection, high levels of both IgxVI and IgG antibodies against the hepatitis D virus become detectable after infection. Both IgM and IgG antibodies persist in serum as long as the patient remains infected.

Hepatitis D virus co-infection often is not diagnosed. In cases in which acute hepatitis B is not too severe, the doctor will not search for hepatitis D co-infection. If liver disease is unusually severe in a highrisk individual, testing for antibodies against hepatitis D virus may be performed and the diagnosis of acute co-infection made. In chronic hepatitis D, which occurs usually as superinfection, the presence of IgG antibodies in blood against hepatitis D virus, in a patient with detectable blood HBsAg, establishes the diagnosis. Testing will usually be performed in a patient with known chronic hepatitis B whose condition deteriorates.

 

More information on Multaq Lawsuit

While tests for IgG against hepatitis D virus are commercially available in the United States, tests for IgM antibodies are available only in research laboratories. Tests for a hepatitis D virus protein known as hepatitis D antigen and PCR tests for hepatitis D virus RNA are also available in research laboratories. They are not part of routine diagnostic testing, however. Tests for hepatitis D antigen and viral RNA directly detect the presence of virus in the patient’s blood.

 

Information from other sources on Multaq Lawsuit

Prevention

Because the hepatitis D virus needs hepatitis B’ virus to replicate, coinfection can be prevented if hepatitis B virus infection is prevented. Patients immune to hepatitis B infection cannot get infected with the hepatitis D virus. Therefore, vaccination against hepatitis B virus will eliminate the chance of contracting hepatitis D. As a result, universal vaccination for hepatitis B should theoretically eliminate hepatitis D as a human disease.

Individuals not immune to hepatitis B infection, who have knowingly been exposed to the hepatitis B and hepatitis D viruses, can receive passive immunization with hepatitis B immune globulin (HBIG). Prevention of hepatitis B virus infection by HBIG will not permit hepatitis D virus infection. No vaccine exists to prevent hepatitis D virus superinfection of persons with chronic hepatitis B virus infection. In these cases, prevention rests entirely upon avoiding high-risk behaviors. High-risk sexual activities should be avoided and latex condoms used. Intravenous drugs should not be used.

Treatment

Treatment of acute hepatitis D virus co-infection is supportive. Either the patient gets better spontaneously or develops fulminant hepatic failure. Emergency liver transplantation is an option for fulminant hepatic failure. In chronic hepatitis D infection, treatment with interferon alpha is a consideration. Although not much data are available at present, some studies suggest that higher doses of interferon alpha, such as 10 million units every day, are necessary in hepatitis D co-infection compared to the 5 million units used every day for chronic hepatitis B.

 

Our use of the term or terms Multaq Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawsuit visit our site often.

http://www.seedol.com

Multaq Lawyer

Multaq Lawyer :

Hepatitis E

The hepatitis E virus is a small, spherical virus that has been provisionally classified as a member of the Caliciviridae family. It is possible that this family assignment will change because the hepatitis E viral genome is different than that of most other caliciviruses. Its genome is composed of RNA.

The hepatitis E virus causes only acute liver disease. The disease caused by hepatitis E virus infection is known as hepatitis £, which is very similar to hepatitis A in its symptoms and clinical course. The disease can range from extremely mild to fulminant hepatic failure. Some cases of acute infection with hepatitis E virus may not produce any symptoms at all and go undiagnosed. In most hepatitis E outbreaks, the highest rates of clinically evident hepatitis have occurred in young to middle-age adults. It is possible that infected children, as is the case with hepatitis A, are more likely to have no obvious disease after infection. The time from infection to symptoms varies from fifteen to sixty days, with forty days being the average. It is not yet clear when the greatest danger of infecting others occurs, but virus excretion in feces has been demonstrated up to fourteen days after acute illness.

Patients with relatively mild disease may suffer from nausea, vomiting, fever, fatigue, and loss of appetite. Blood tests may reveal elevations in ALT and AST activities and possibly elevations in bilirubin concentration. Patients with more severe disease may develop jaundice, and blood tests will reveal an elevation in bilirubin concentration, a prolongation of prothrombin time, and sometimes markedly elevated

ALT and AST activities. Most patients with mild or moderate hepatitis E recover without complications. Some patients become so sick that they cannot eat or drink. Some patients with hepatitis E infection develop fulminant hepatic failure.

 

More information on Multaq Lawyer

Transmission

Hepatitis E virus infection does not occur in the United States. Virtually all cases reported in the United States involve travelers returning from parts of the world where hepatitis E is common. Outbreaks have occurred in many geographic locations around the world, mostly In underdeveloped countries. Hepatitis E virus is primarily spread by the fecal-oral route, that is, from feces of infected individuals to food or water thar is then ingested by others. Drinking contaminated water is probably the most common mode of infection. Person-to-person transmission appears to be rare. Similar to hepatitis A, hepatitis E is more common in parts of the world having poor sanitary conditions. Travelers from developed countries to such regions are at increased risk for infection from hepatitis E.

Information from other sources on Multaq Lawyer

Diagnosis

The clinical diagnosis of hepatitis E infection is suggested by the sudden onset of liver disease fifteen to sixty days after suspected exposure to the hepatitis E virus. Sometimes, patients will present with new- onset jaundice immediately suggesting acute liver disease. Such patients should be questioned about a risk factor for hepatitis E, which in North America and most European countries is recent travel to an area where the disease is endemic. Southern and central Asia, northern Africa, and Central America are regions of the world where hepatitis E outbreaks are the most common.

The diagnosis of hepatitis E infection is made through blood testing. Tests for antibodies against the hepatitis E virus are not commercially available in the United States but are available at research laboratories or specialized centers, such as the U.S. Centers for Disease Control and Prevention. Both IgM. and IgC antibodies against the hepatitis E virus are elicited following acute viral infection.

 

Our use of the term or terms Multaq Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawyer visit our site often.

http://www.seedol.com

Multaq

Multaq :

Prevention

The most important issue regarding hepatitis E is prevention, which depends primarily upon avoiding contaminated water. Travelers to developing countries should avoid drinking from local water supplies and consuming beverages with ice of unknown purity. Uncooked shellfish, uncooked fruits, and vegetables that are not peeled or prepared by the traveler should not be consumed. At the present time, there are no postexposure prophylactic measures nor vaccines for hepatitis E.

Treatment

There is no specific treatment for hepatitis E. In many cases, the disease is mild and self-limiting. If the patient is so sick that he or she cannot eat or drink, hospitalization may be necessary for the administration of intravenous fluids. The patient can be discharged once there is adequate oral intake. In serious cases, generally those causing fulminant hepatic failure, hospitalization and intensive care are required. Preferably, these patients should be hospitalized in a medical center where ¡iver transplantation can be performed if necessary.

 

More information on Multaq

Other Viruses That Cause Hepatitis

Hepatitis A, B, C, D, and E viruses are the major hepatotropic viruses that cause liver disease in humans (there is no hepatitis F). Some other viruses can also cause acute liver disease in otherwise healthy individuals. In most cases, these viruses cause systemic diseases that concurrently affect the liver. These viruses include dengue virus, yellow fever virus, and Epstein-Barr virus (EBV), which causes mononucleosis. Individuals with mononucleosis can suffer from a mild form of acute hepatitis that always resolves. Available data suggest that poxvirus and measles virus cause hepatitis in children.

Information from other sources on Multaq

Some viruses that are generally harmless in healthy individuals may cause liver disease in patients with compromised immune systems. These viruses may infect patients with AIDS or cancer. They may also infect patients who have received organ transplants and are taking medications that suppress their immune systems. The most important of these viruses is cytomegalovirus, or CMV. CMV can cause hepatitis in recipients of organ transplants, including transplanted livers. CMV can also cause hepatitis and serious bile duct abnormalities in patients with AIDS.

Some doctors will test patients with chronic hepatitis for antibodies against CMV and EBV. These viruses are endemic in the human population, and the detection of IgG antibodies means virtually nothing. Furthermore, these two viruses do not cause any significant chronic liver disease in people with normal immune systems. If someone tells you that you have chronic hepatitis caused by EBV or CMV, you should be suspicious and see another doctor.

 

Our use of the term or terms using Multaq is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq visit our site often.

http://www.seedol.com

Actos Bladder Cancer

Actos Bladder Cancer :

When you met with your doctor to discuss your diagnosis, he or she probably described your cancer stage with a combination of letters and numerals, which you may not have understood.

Staging is a way to determine how deeply your cancer has penetrated into the bladder and muscle, surrounding tissue, or distant organs. The pathologist stages the tissues from your biopsy, and your doctor uses that information along with your scan, cystoscopy, and X-ray results to determine where you are in the disease process and what treatment is best for you.

 

 

More information on Actos Bladder Cancer

If the results of your tests-—-either scans or biopsies-—- show that cancer has spread to other tissue or organs, your doctor will want to confirm that. Clarification of the stage of your cancer comes through looking at the cancer cells from those organs under the microscope. Tissue samples may be taken at the time of your biopsy, or sometimes a needle biopsy is done, bypassing the need for additional surgery.

Pathologists stage bladder-cancer tissue by using a standardized system known as TNM, which stands for tumor- nodes-metastases. A typical TNM might be “T2aNlM0” (T-two-a-N-one-M-zero). Looks like mumbo jumbo, doesn’t it? Try thinking of it as medical shorthand, with each letter and numeral having a defined value that gives doctors and pathologists a specific, consistent way to describe how deeply a cancer has invaded the body’s tissue and organs.

Information from other sources on Actos Bladder Cancer

The TNM system uses the letters T, N, and M followed by numerals to describe the stage of invasiveness of your cancer.

The letter T followed by a numeral from one to four (1 to 4) describes the depth of invasiveness of your tumor. The lower the number, the less invasive the cancer.

The T scale has additional, more detailed levels as well. These levels add the lowercase letters a and b to the T score to delineate more precisely how far into the bladder your cancer has spread and whether it has moved into other areas of your body. It fine-tunes the pathology information to help your doctor make treatment recommendations.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Reclast Side Effects

Reclast Side Effects: Numerous health problems can lead to kidney failure. The four main causes are diabetes, hypertension, glomerular diseases, and polycystic kidney disease (PKD). Genetics plays a role in most causes of kidney failure, and kidney failure may result from a specific defect inherited from one or both parents. PKD is primarily an inherited kidney disease.

Genetics is not the whole story, however. Lifestyle and other environmental factors may also be significant influences. This chapter begins with a primer on the genetic and environmental factors contributing to kidney failure. Knowledge of these factors will help you understand how you might slow the progression of your disease.

For all organs of the body, our genes issue the instructions (or blueprints) to make proteins while we are in the womb. For organs to develop correctly, certain processes must happen in an exact way. It starts when a sperm fertilizes the egg. The cells in the resulting embryo, possessing two copies of each gene, one from each parent, begin to divide. As the embryo grows, copies of genes inherited from each parent must be reproduced identically in each new cell, so that all the cells in the developing fetus (and eventually in the person’s body) will have the same set of genetic blueprints. During a person’s lifetime, many of the cells in the body will die and be replaced with new ones. These new cells generally also contain the same blueprints.

Although rare, mistakes can occur when genes are copied. Called mutations, these mistakes can cause the organs to work improperly. If a house’s blueprints are wrong, a door might be located in the wrong place or the lighting system might fail because of incorrect wiring. In people, gene mistakes are passed along to their children and can cause them to inherit a disease. For example, mutations in genes that make or control kidneys can malfunction, leading to disease.

More information on Reclast Side Effects

Behavioral and environmental factors can also contribute to the expression or progression of a disease. In the case of kidney failure, an improper diet and lack of exercise or other lifestyle factors can contribute greatly to a person’s medical status. We do not deliberately set out to make ourselves ill. However, with the stresses of our culture and everyday life, it can be easy to neglect our own health. Between work, family, and social obligations, we are so busy that we may have little time to cat properly or to get adequate exercise. Over time, our health can begin to fail without our even knowing it.

When people don’t eat right and don’t exercise, they are more likely to be overweight or obese. Obesity has reached epidemic proportions in the United States and in other developed countries. According to a rccent study, 66.3 percent of Americans arc overweight, obese, or morbidly obese.1 African Americans and Hispanic Americans have a higher prevalence of obesity than non-Hispanic whites. Moreover, women across all races are more obese than men. Obesity increases with age, leveling off by age 60 or declining thereafter.

Obesity may lead to other health complications—including kidney failure—because obesity makes people more likely to develop diabetes and hypertension. Excess weight can also cause coronary heart disease, high cholesterol levels, and stroke, which can lead to death. References to the symptoms of kidney disorders by the ancient Greeks suggest that we have known about kidney failure for thousands of years. We weren’t able to analyze kidneys and other organs until the nineteenth century however. In 1827, the English physician Richard Bright first described the symptoms of kidney failure.

Information from other sources on Reclast Side Effects

In the twenty-first century kidney failure is still incurable, but it can be prevented and treated. With dialysis and transplantation, people with kidney failure can continue to have productive lives. Nevertheless, failing kidneys take a very high medical, emotional, and financial toll. There is no cure for kidney failure, but knowing its causes can help prevent, delay, or prepare for it.

Approximately one-half million people in the United States are living with kidney failure. In most cases, diabetes and hypertension are the causes. Both are preventable. Glomerular disorders, which can have both environmental and genetic origins, are another cause of kidney failure. There are also inherited causes of kidney failure, like PKD. If a person inherits mutated genes, the disease will develop, although the progression of the disease varies among families and individuals. This chapter presents a brief overview of each of these four leading causes of kidney failure.

Diabetes (also known as diabetes mellitus) is the leading cause of kidney failure in the United States and accounts for 38 percent of cases. Because of rising obesity rates, diabetes rates are increasing, even among children. As many as 20.6 million people have diabetes. As people age, they become more susceptible to diabetes. About one-half of all people with diabetes are over 60 years old. Across the population, slightly more men than women have diabetes, and it disproportionately affects Native Americans, non-Hispanic African Americans, and Hispanic Americans. Understanding the underlying causes of diabetes is essential for learning how to prevent and treat it.

Our use of the term or terms Reclast Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Reclast Side Effects visit our site often.

http://www.seedol.com

Getting The Best Deal For Your Structured Settlement

It goes without saying that anyone who offers to buy your structured settlement and annuity for a lump sum are in business to make a living – nobody does this out of the sheer goodness of his or her heart. As with every other financial transaction, there are going to be fees involved, which are going to come out of the full amount. In other words, in accepting a settlement lump sum, you are going to get less than you would had you held on to it and accepted the structured settlement payments over time.

The difference is what the funding organization gets for providing you with this service.

The good news for you is that the structured settlement funding industry has gotten quite competitive in recent years – and that competition is heating up all the time. This makes it easier for you to find a buyer who will give you the best deal on your annuity payments or structured settlement. Because the “discount rate” – the percentage of the entire sum that the funding company takes as a fee for this service – can vary from as little as 8% to as much as 18%, it’s a good idea to do some shopping around.

On the other hand, “cheap” does not always mean “better.” You may be better off paying a little more to a company that is reputable and provides a superior level of service that paying less to a company that is going to pull tricks such as prolonging the court process – one of a number of tricks that are sometimes used in order to squeeze a little more out of a client.

Your first step should be to go to the Better Business Bureau and check out some funding companies. Most companies that have been in business for several years or longer will receive some feedback from customers through the BBB. However, if a company has had more than five complaints in recent years and/or a number of unresolved complaints, that’s a red flag – meaning you probably don’t want to do business with them.

You also need to do your own due diligence. Know beforehand exactly how much you think your annuity or structured settlement is worth – after all, though you won’t get full value for it, you want to retain as much value as possible. Solicit competitive quotes from a number of different structured settlement companies, and insist on full disclosure of any and all fees and discounts.

The structured settlement companies with which you consider doing business should be operating in your best interests, regardless of the profit motive. If their professionals feel that selling your structured settlement or annuity is not a good choice for you (and for some people, it isn’t), they should tell you this and explain exactly why.  Unfortunately not all companies are created equal.

http://www.seedol.com

Annuity Payments vs. Lump Sum Payment: Tax Implications

The U.S. Internal Revenue Code (“IRC”) is far from simple as most of us are aware, and consists of several thousands of pages. It is also constantly changing. This complexity and state of constant flux is not necessarily a bad thing however. In some cases, it can work to one’s advantage, particularly when it comes to certain types of annuities – even if those annuities are sold for a lump sum.

Before going any further, two things need to be said; first, neither CBC nor the company’s employees or contractors are offering tax advice here. Tax law is a legal specialty all its own, and every individual’s financial circumstance is unique. Anyone facing decisions about liquidating an annuity or structured payment should consult a tax professional before committing to any course of action. Secondly, there are several different types of annuities and structured payouts, all of which are treated differently under the  IRC.

Annuities and structured payments generally fall into one of three broad categories:

  • Investments: in the past, this was usually a method to ensure guarantee income for a set period of time or for the remainder of a measuring life. This is commonly used as a retirement tool.  Today, there are many different types of accounts and investments that do this, such as fully taxable policies, deferred policies which can be held individually or in retirement accounts such as IRAs and 401(k) plans.
  • Structured Settlements: these may result from a successful legal action (lawsuit) or an insurance claim. Personal injury structured settlements are often paid in monthly or annual installments.
  • Lottery Winnings: Those rare individuals whose number finally comes up are usually offered a choice between a lump sum payment (which is about 60% of the total jackpot), or yearly payments spread out over 20 years.

Selling structured payments in exchange for a lump sum involves all three.

If you purchase a taxable investment annuity or win a lottery, taxes will be withheld from your prize before you receive it.

As far as a court-awarded settlements or private legal settlements for personal injury settlements, the IRS has ruled that such payments are non-taxable by the Federal or state governments.

You will be interested to know that in Private Letter Ruling 119273-97, the IRS says that you incur no tax liability when you sell your structured settlement to another individual or business entity. If however you are doing this in order to invest in something else, any interest or return on that investment is subject to the normal tax rate.

http://www.seedol.com

Selling Your Structured Settlement: Avoiding Rip-offs

It’s no secret that in America today consumers have come to doubt the ethical standard by which Wall Street and financial institutions abide.  Certainly the events beginning in 2008 have caused many to question the effectiveness of the rules and regulations governing many financial products.  While very few individuals such as Bernie Madoff have gone to prison in order to serve as token examples for an increasingly enraged citizenry, the fact is that when it comes to engaging in virtually any type of financial transaction involving large sums of money, you need to protect yourself.

Despite deregulation of financial services over the past thirty years and limited enforcement of existing laws, you’ll be happy to know that when it comes to factoring companies – that is to say, structured settlement buyers – there are substantial legal protections still in place for sellers.

The Structured Settlement Protection Act of 2002 is federal legislation that mandates a number of safeguards for recipients seeking to liquidate all or a portion of their future payments in order to maintain the favorable tax treatment of personal injury settlements. The main protection is the requirement that all structured settlement transactions conducted by a factoring company be reviewed and approved by a court of law before they are allowed to go through.  It also requires full disclosure of all terms up front as well as a “cooling off” period during which a seller may withdraw from the transaction.

The best way to protect yourself, however, is to trust your instincts and do your due diligence. Check the Better Business Bureau and read up on the company’s profile. Virtually every business currently operating receives a few complaints; however, if there is an unusually high number of these complaints and many of them are listed as “unresolved,” it should serve as a warning. You will also want to make certain that the factoring company with which you are doing business is licensed, bonded and insured (where applicable) to ensure the company you are dealing with is likely to be around for the long term.

Take time to look into the company’s relationships with insurance companies and litigation firms as well as its former clients. Strong, positive relationships are a good indicator that the company is operating in an honest and ethical manner.

If the structured settlement buyer with which you are doing business employs high-pressure tactics and is circumspect about the terms of the deal – or makes unrealistic promises (such as a guarantee that you will receive your check in an unreasonably short period of time), chance are that it’s time to seek another buyer.

You should also take nothing for granted: read all documents with which you are presented, and have your own attorney review them if you find them difficult to understand.

http://www.seedol.com

Annuity Payments vs. Lump Sum Payment: Tax Implications

The U.S. Internal Revenue Code is far from simple as most of us are aware, and consists of several thousands of pages. It is also constantly changing. This complexity and state of constant flux is not necessarily a bad thing however. In some cases, it can work to one’s advantage, particularly when it comes to certain types of annuities – even if those annuities are sold for a lump sum.

Before going any further, two things need to be said; first, neither CBC nor the company’s employees or contractors are offering tax advice here. Tax law is a legal specialty all its own, and every individual’s financial circumstance is unique. Anyone facing decisions about liquidating an annuity or structured payment should consult a tax professional before committing to any course of action. Secondly, there are several different types of annuities and structured payouts, all of which are treated differently under the IRC.

Annuities and structured payments generally fall into one of three broad categories:

  • Investments: in the past, this was usually a life insurance policy which, if the insured lived beyond the term of the policy, would start providing payments on a scheduled basis. It is how many people funded their retirements in last century. Today, there are many different types of accounts and investments that do this, such as IRAs and 401(k) plans.
  • Settlements: these may result from a successful legal action (lawsuit) or an insurance claim. When the amount is several hundreds of thousands, or millions of dollars, such settlements are paid in yearly installments.
  • Lottery Winnings: Those rare individuals whose number finally comes up are usually offered a choice between a lump sum payment (which is about 60% of the total jackpot), or yearly payments spread out over 20 years.

Selling structured settlements in exchange for a lump sum involves only the last two.

If you win a lottery of course, taxes will be withheld from your prize before you receive it – so even if you sell these structured payments later, it won’t make any difference, since you’ve already paid taxes on it.

As far as a court award, the IRS has ruled that such payments are non-taxable by the Federal or state governments.

You will be interested to know that in Private Letter Ruling 119273-97, the IRS says that you incur no tax liability when you sell your structured settlement to another individual or business entity. If however you are doing this in order to invest in something else, any interest or return on that investment is subject to the normal tax rate.

http://www.seedol.com